Statistics from Altmetric.com
THERE was a mistake in the veterinary medicines product update from the Veterinary Medicines Directorate published in VR, May 1, 2010, vol 166, pp 544-545.
For Prilactone, the article stated that a new indication: ‘The product has been shown to extend life expectancy in treated dogs’ had been added. This is not correct.
In reality the amendment was in the ‘Pharmacodynamic properties’ section. This section now reads ‘In a clinical study investigating the survival time in dogs with congestive heart failure, there was a 65 % reduction in the relative risk of mortality at 15 months in dogs treated with spironolactone in combination with standard therapy compared to dogs treated with standard therapy alone. (Mortality was classified as death or euthanasia due to heart failure).’
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.